Fibromyalgia, Cognitive Rehabilitation Software

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorSavaş Karpuz

About this trial

In recent years, especially in developed countries, FMS has emerged as a serious social problem by decreasing labour force and quality of life. Especially clinicians have started to consider cognitive dysfunction in FMS as a separate clinical condition. In the light of the data obtained, can say that cognitive dysfunction increases in the presence of depression, anxiety, sleep disorders, endocrine imbalances and pain.

Neuroscience and technological advances make it possible to meet the demand for care and improve the quality of stimulation by enabling the automation of many cognitive training procedures, improving patient record reliability and optimising performance of disability functions. The recently implemented RehaCom and HeadApp programmes (Schuhfried, Austria). excellent results have been reported in clinical practice with no significant adverse effects.

This study will investigate the effectiveness of a cognitive rehabilitation programme using computer software in female patients with fibromyalgia.

Eligibility criteria

Qualifiers

Being a woman

Diagnosed with fibromyalgia

18-65 years old

Disqualifiers

concomitant neurological disorder, learning disorder or cognitive impairment

current alcohol or recreational drug dependence or long-term (≥5 years) history of substance abuse

visual or hearing impairment that would interfere with cognitive testing

diagnosis of untreated obstructive sleep apnoea,

Trial design

Treatments tested in this trial

  • cognitive rehabilitation with computer software

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Savaş Karpuz

Lead sponsor

Konya Beyhekim Training and Research Hospital

Sponsor institution